Principal Financial Group
VKTX icon

Principal Financial Group’s Viking Therapeutics VKTX Stock Holding History

Principal Financial Group’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3M Sell
494,509
-30,975
-6% -$1M 0.01% 1015
2026
Q1 		$17.1M Buy
525,484
+11,753
+2% +$378K 0.01% 1016
2025
Q4 		$18.1M Sell
513,731
-271
-0.1% -$9.6K 0.01% 959
2025
Q3 		$13.5M Sell
514,002
-51,064
-9% -$1.52M 0.01% 1113
2025
Q2 		$15M Sell
565,066
-33,069
-6% -$871K 0.01% 1028
2025
Q1 		$14.4M Sell
598,135
-30,629
-5% -$968K 0.01% 1046
2024
Q4 		$25.3M Buy
628,764
+35,236
+6% +$2.01M 0.01% 721
2024
Q3 		$37.6M Buy
593,528
+136,729
+30% +$8.02M 0.02% 563
2024
Q2 		$24.2M Buy
456,799
+95,960
+27% +$6.29M 0.01% 750
2024
Q1 		$29.6M Buy
360,839
+349,725
+3,147% +$15.6M 0.02% 687
2023
Q4 		$207K Buy
11,114
+971
+10% +$12.7K ﹤0.01% 2160
2023
Q3 		$112K Sell
10,143
-1,208
-11% -$17.3K ﹤0.01% 2265
2023
Q2 		$184K Buy
+11,351
New +$238K ﹤0.01% 2196
2021
Q4 		– Sell
-14,727
Closed -$92K – 2642
2021
Q3 		$92K Sell
14,727
-2,387
-14% -$14.7K ﹤0.01% 2510
2021
Q2 		$103K Buy
17,114
+946
+6% +$5.62K ﹤0.01% 2530
2021
Q1 		$102K Buy
16,168
+1,137
+8% +$8K ﹤0.01% 2422
2020
Q4 		$85K Buy
15,031
+329
+2% +$1.99K ﹤0.01% 2370
2020
Q3 		$86K Sell
14,702
-728
-5% -$5.01K ﹤0.01% 2277
2020
Q2 		$111K Buy
15,430
+4,889
+46% +$32.5K ﹤0.01% 2241
2020
Q1 		$49K Hold
10,541
– – ﹤0.01% 2155
2019
Q4 		$85K Buy
+10,541
New +$76.8K ﹤0.01% 2195

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Principal Financial Group's VKTX Position: Q2 2026 in Review

Principal Financial Group reduced its Viking Therapeutics (VKTX) stake by 5.9% in Q2 2026, selling an estimated $1M and leaving 494,509 shares worth $19.3M. The position accounts for 0.01% of the portfolio, ranked #1015.

Principal Financial Group first reported a position in VKTX in Q4 2019 and has held it in 21 quarters since. The position peaked at $37.6M in Q3 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Principal Financial Group held 494,509 shares of Viking Therapeutics worth $19.3M as of Q2 2026.
  • Principal Financial Group sold 30,975 Viking Therapeutics shares in Q2 2026, an estimated $1M.
  • Viking Therapeutics made up 0.01% of Principal Financial Group's portfolio in Q2 2026, its #1015 holding.
  • Principal Financial Group first reported a position in Viking Therapeutics in Q4 2019 and has held it in 21 quarters since.
  • Principal Financial Group's Viking Therapeutics position peaked at $37.6M in Q3 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.